Patents by Inventor Pran Kishore Deb

Pran Kishore Deb has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • (6-methyl-4-substitutedphenyl-2-oxo/thioxo-1,2,3,4-tetrahydropyrimidin-5-yl)(piperidin-1-yl)methanones as antitubercular agents
    Patent number: 11912683
    Abstract: Compounds for treating tuberculosis and, particularly, anti-tubercular compounds that are (6-methyl-4-substitutedphenyl-2-oxo/thioxo-1,2,3,4-tetrahydropyrimidin-5-yl)(piperidin-1-yl)methanones and their use as anti-tubercular agents are provided.
    Type: Grant
    Filed: September 13, 2023
    Date of Patent: February 27, 2024
    Assignee: KING FAISAL UNIVERSITY
    Inventors: Katharigatta N. Venugopala, Keshab M. Bairagi, Pran Kishore Deb, Melendran Pillay, Mohamed A. Morsy, Susanta K. Nayak, Sandeep Chandrashekharappa, Osama I. Alwassil
  • Benzylidene derivatives of fenobam as anti-inflammatory agents
    Patent number: 11905279
    Abstract: Benzylidene derivatives of fenobam compounds, a method of synthesizing said compounds, a pharmaceutical composition comprising said compounds and a suitable carrier, and a method of using the compounds. The benzylidene derivatives of fenobam, identified as COX-1 and COX-2 inhibitors, are useful as anti-inflammatory agents.
    Type: Grant
    Filed: October 13, 2023
    Date of Patent: February 20, 2024
    Assignee: KING FAISAL UNIVERSITY
    Inventors: Katharigatta N. Venugopala, Pran Kishore Deb, Wafa Hourani, Nefisath P, Mohamed A. Morsy, Shashiprabha S, Jagadeesh Prasad Dasappa, Rashmi Venugopala, Raghu Prasad Mailavaram
  • Substituted phenyl quinolin-l-ium bromide derivative as anti-tubercular agents
    Patent number: 11884631
    Abstract: Compounds for treating tuberculosis and, particularly, to anti-tubercular compounds that are phenyl quinolin-1-ium bromide derivatives and their use as anti-tubercular agents.
    Type: Grant
    Filed: August 3, 2023
    Date of Patent: January 30, 2024
    Assignee: KING FAISAL UNIVERSITY
    Inventors: Katharigatta N. Venugopala, Pran Kishore Deb, Melendran Pillay, Sandeep Chandrashekharappa, Mohamed A. Morsy, Bandar Adlhubiab, Mahesh Attimarad, Anroop B. Nair, Nagaraja Sreeharsha, Christophe Tratrat, Sheena Shashikanth
  • 5-(substitutedphenyl)-7-imino-7,8-dihydropyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dione analogues as anti-inflammatory agents
    Patent number: 11884677
    Abstract: Compounds for treating an inflammatory disease, disorder, or condition and, particularly, to compounds that are 5-(substitutedphenyl)-7-imino-7,8-dihydropyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dione analogues and their use as anti-inflammatory agents.
    Type: Grant
    Filed: August 9, 2023
    Date of Patent: January 30, 2024
    Assignee: KING FAISAL UNIVERSITY
    Inventors: Katharigatta N. Venugopala, Pran Kishore Deb, Vinuta Kamat, Rangappa Santosh, Boja Poojary, Manohar S. Kugaji, Vijay M. Kumbar, Mohamed A. Morsy, Bandar Aldhubiab, Mahesh Attimarad, Anroop B. Nair, Nagaraja Sreeharsha
  • Ethyl 2-substituted-1-(substitutedbenzoyl)-7-methylpyrrolo[1,2-a]quinoline-3-carboxylate derivatives as anti-tubercular agents
    Patent number: 11845746
    Abstract: Compounds for treating tuberculosis and, particularly, anti-tubercular compounds that are ethyl 2-substituted-1-(substitutedbenzoyl)-7-methylpyrrolo[1,2-a]quinoline-3-carboxylate derivatives and their use as anti-tubercular agents are provided.
    Type: Grant
    Filed: August 23, 2023
    Date of Patent: December 19, 2023
    Assignee: KING FAISAL UNIVERSITY
    Inventors: Katharigatta N. Venugopala, Pran Kishore Deb, Melendran Pillay, Sandeep Chandrashekharappa, Mohamed A. Morsy, Bandar Aldhubiab, Mahesh Attimarad, Anroop B. Nair, Nagaraja Sreeharsha, Christophe Tratrat, Sheena Shashikanth, Vijaykumar Uppar, Basavaraj Padmashali
  • 7-isopropyl 1-ethyl/methyl 3-(substituted benzoyl)-2-substituted indolizine-1,7-dicarboxylates as anti-tubercular agents
    Patent number: 11807640
    Abstract: The substituted indolizine dicarboxylates are antibacterial agents. The emergence of drug-resistant bacteria calls for constant development of new antibacterial agents with the aim of generating medicaments that are potent against drug sensitive and resistant bacteria and are well tolerated. The present compounds are not only new, but have very valuable antimicrobial properties. These compounds showed a broad spectrum of activity against tuberculosis mycobacteria. Based on their pharmacological profiles, the present compounds may find important clinical applications for severe infectious diseases and tuberculosis.
    Type: Grant
    Filed: March 28, 2023
    Date of Patent: November 7, 2023
    Assignee: KING FAISAL UNIVERSITY
    Inventors: Katharigatta N. Venugopala, Bandar Aldhubiab, Mohamed A. Morsy, Mahesh Attimarad, Anroop B. Nair, Nagaraja Sreeharsha, Christophe Tratrat, Sandeep Chandrashekharappa, Melendran Pillay, Pran Kishore Deb, Sheena Shashikanth
  • Antitubercular compounds
    Patent number: 11530217
    Abstract: Anti-tubercular compounds include trisubstituted indolizines having the following structural formula: wherein R1 is selected from the group consisting of 4-OCH3, 4-Cl, 4-Br, 4-F, 2-NO2, 3,5-CF3, CN, CH3, R2 is COOCH3, COOC2H5, and R3 is H and COOCH3.
    Type: Grant
    Filed: June 29, 2022
    Date of Patent: December 20, 2022
    Assignee: KING FAISAL UNIVERSITY
    Inventors: Katharigatta N. Venugopala, Mahesh Attimarad, Anroop B. Nair, Nagaraja Sreeharsha, Mohamed A. Morsy, Sandeep Chandrashekharappa, Melendran Pillay, Pran Kishore Deb